<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-04-29T00:40:24Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:9760138" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:9760138</identifier>
        <datestamp>2022-12-20</datestamp>
        <setSpec>cedr</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" id="cre2638" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Clin Exp Dent Res</journal-id>
              <journal-id journal-id-type="iso-abbrev">Clin Exp Dent Res</journal-id>
              <journal-id journal-id-type="doi">10.1002/(ISSN)2057-4347</journal-id>
              <journal-id journal-id-type="publisher-id">CRE2</journal-id>
              <journal-title-group>
                <journal-title>Clinical and Experimental Dental Research</journal-title>
              </journal-title-group>
              <issn pub-type="epub">2057-4347</issn>
              <publisher>
                <publisher-name>John Wiley and Sons Inc.</publisher-name>
                <publisher-loc>Hoboken</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC9760138</article-id>
              <article-id pub-id-type="pmcid">PMC9760138</article-id>
              <article-id pub-id-type="pmc-uid">9760138</article-id>
              <article-id pub-id-type="pmid">35894289</article-id>
              <article-id pub-id-type="pmid">35894289</article-id>
              <article-id pub-id-type="doi">10.1002/cre2.638</article-id>
              <article-id pub-id-type="publisher-id">CRE2638</article-id>
              <article-categories>
                <subj-group subj-group-type="overline">
                  <subject>Original Article</subject>
                </subj-group>
                <subj-group subj-group-type="heading">
                  <subject>Original Articles</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Fermented lingonberry juice's effects on active MMP‐8 (aMMP‐8), bleeding on probing (BOP), and visible plaque index (VPI) in dental implants—A clinical pilot mouthwash study</article-title>
                <alt-title alt-title-type="left-running-head">LÄHTEENMÄKI <sc>et al.</sc>
</alt-title>
              </title-group>
              <contrib-group>
                <contrib id="cre2638-cr-0001" contrib-type="author">
                  <name>
                    <surname>Lähteenmäki</surname>
                    <given-names>Hanna</given-names>
                  </name>
                  <xref rid="cre2638-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="cre2638-cr-0002" contrib-type="author">
                  <name>
                    <surname>Tervahartiala</surname>
                    <given-names>Taina</given-names>
                  </name>
                  <xref rid="cre2638-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="cre2638-cr-0003" contrib-type="author">
                  <name>
                    <surname>Räisänen</surname>
                    <given-names>Ismo T.</given-names>
                  </name>
                  <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-5821-5299</contrib-id>
                  <xref rid="cre2638-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="cre2638-cr-0004" contrib-type="author" corresp="yes">
                  <name>
                    <surname>Pärnänen</surname>
                    <given-names>Pirjo</given-names>
                  </name>
                  <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-2994-8690</contrib-id>
                  <xref rid="cre2638-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <address>
                    <email>pirjo.parnanen@helsinki.fi</email>
                  </address>
                </contrib>
                <contrib id="cre2638-cr-0005" contrib-type="author">
                  <name>
                    <surname>Sorsa</surname>
                    <given-names>Timo</given-names>
                  </name>
                  <xref rid="cre2638-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="cre2638-aff-0002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
              </contrib-group>
              <aff id="cre2638-aff-0001">
                <label>
                  <sup>1</sup>
                </label>
                <named-content content-type="organisation-division">Department of Oral and Maxillofacial Diseases, Head and Neck Center</named-content>
                <institution>University of Helsinki and Helsinki University Hospital</institution>
                <city>Helsinki</city>
                <country country="FI">Finland</country>
              </aff>
              <aff id="cre2638-aff-0002">
                <label>
                  <sup>2</sup>
                </label>
                <named-content content-type="organisation-division">Department of Dental Medicine, Division of Periodontology</named-content>
                <institution>Karolinska Institutet</institution>
                <city>Huddinge</city>
                <country country="SE">Sweden</country>
              </aff>
              <author-notes>
                <corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold> Pirjo Pärnänen, Department of Oral and Maxillofacial Diseases, Head and Neck Center, University of Helsinki and Helsinki University Hospital, PO Box 63 (Haartmaninkatu 8), 00014 Helsinki, Finland.<break/>
Email: <email>pirjo.parnanen@helsinki.fi</email>
<break/>
</corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>27</day>
                <month>7</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="collection">
                <month>12</month>
                <year>2022</year>
              </pub-date>
              <volume>8</volume>
              <issue seq="30">6</issue>
              <issue-id pub-id-type="doi">10.1002/cre2.v8.6</issue-id>
              <fpage>1322</fpage>
              <lpage>1330</lpage>
              <history>
                <date date-type="rev-recd">
                  <day>13</day>
                  <month>7</month>
                  <year>2022</year>
                </date>
                <date date-type="received">
                  <day>09</day>
                  <month>9</month>
                  <year>2021</year>
                </date>
                <date date-type="accepted">
                  <day>13</day>
                  <month>7</month>
                  <year>2022</year>
                </date>
              </history>
              <permissions>
                <!--&#x000a9; 2022 The Authors. Clinical and Experimental Dental Research published by John Wiley & Sons Ltd.-->
                <copyright-statement content-type="article-copyright">© 2022 The Authors. <italic toggle="yes">Clinical and Experimental Dental Research</italic> published by John Wiley &amp; Sons Ltd.</copyright-statement>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="file:CRE2-8-1322.pdf"/>
              <abstract>
                <title>Abstract</title>
                <sec id="cre2638-sec-0010">
                  <title>Objectives</title>
                  <p>We aimed to study the effects of fermented lingonberry juice (FLJ) as a mouthwash on the levels of active matrix metalloproteinase‐8 (aMMP‐8) in peri‐implant sulcular fluid (PISF), bleeding on probing (BOP), and visible plaque index (VPI). We hypothesized that FLJ rinsing could reduce inflammation (aMMP‐8 and BOP) and microbial load (VPI) in the oral cavity, especially around dental implants.</p>
                </sec>
                <sec id="cre2638-sec-0020">
                  <title>Materials and Methods</title>
                  <p>A clinical pilot study was performed using FLJ as a mouthwash. The inclusion criteria were at least one dental implant in the anterior or posterior areas with a screw‐retained crown. Ten participants used 10 ml of mouthwash twice a day for 15 days, and 10 participants served as the control group. Point‐of‐care tests (POCTs) were used to measure aMMP‐8 levels in the PISF, and BOP and VPI were recorded at the beginning of the trial and after 15 and 30 days.</p>
                </sec>
                <sec id="cre2638-sec-0030">
                  <title>Results</title>
                  <p>The FLJ mouthwash had a reductive effect on aMMP‐8, VPI, and BOP in the mouthwash group; however, there was no significant difference compared to the control group. The difference in VPI and BOP levels between the groups diminished after the lingonberry regimen ended. The decrease in aMMP‐8 levels appeared to continue even after discontinuation of the mouthwash regimen.</p>
                </sec>
                <sec id="cre2638-sec-0040">
                  <title>Conclusion</title>
                  <p>The reduction in the amount of plaque, aMMP‐8, and BOP by FLJ was promising and continuous considering the relatively short study period and sample size. FLJ is a natural and safe supplement for oral and dental implant home care. Further studies are required to verify these promising results.</p>
                </sec>
              </abstract>
              <kwd-group>
                <kwd id="cre2638-kwd-0001">dental implants</kwd>
                <kwd id="cre2638-kwd-0002">lingonberries</kwd>
                <kwd id="cre2638-kwd-0003">mouthwash</kwd>
                <kwd id="cre2638-kwd-0004">
                  <italic toggle="yes">Vaccinium vitis‐idaea</italic>
                </kwd>
              </kwd-group>
              <funding-group>
                <award-group id="funding-0001">
                  <funding-source>
                    <institution-wrap>
                      <institution>Yrjö Jahnssonin Säätiö
</institution>
                      <institution-id institution-id-type="doi">10.13039/100010114</institution-id>
                    </institution-wrap>
                  </funding-source>
                </award-group>
                <award-group id="funding-0002">
                  <funding-source>
                    <institution-wrap>
                      <institution>Paulon Säätiö
</institution>
                      <institution-id institution-id-type="doi">10.13039/501100007417</institution-id>
                    </institution-wrap>
                  </funding-source>
                </award-group>
                <award-group id="funding-0003">
                  <funding-source>
                    <institution-wrap>
                      <institution>Emil Aaltosen Säätiö
</institution>
                      <institution-id institution-id-type="doi">10.13039/501100004756</institution-id>
                    </institution-wrap>
                  </funding-source>
                </award-group>
                <award-group id="funding-0004">
                  <funding-source>
                    <institution-wrap>
                      <institution>Karolinska Institutet
</institution>
                      <institution-id institution-id-type="doi">10.13039/501100004047</institution-id>
                    </institution-wrap>
                  </funding-source>
                </award-group>
                <award-group id="funding-0005">
                  <funding-source>Juhani Ahon Lääketieteen Tutkimussäätiö</funding-source>
                </award-group>
                <award-group id="funding-0006">
                  <funding-source>
                    <institution-wrap>
                      <institution>Orionin Tutkimussäätiö
</institution>
                      <institution-id institution-id-type="doi">10.13039/501100007083</institution-id>
                    </institution-wrap>
                  </funding-source>
                </award-group>
                <award-group id="funding-0007">
                  <funding-source>Minervasäätiö Selma ja Maja‐Lisa Selanderin rahasto</funding-source>
                </award-group>
                <award-group id="funding-0008">
                  <funding-source>Helsingin Seudun Hammaslääkärit r.y.</funding-source>
                </award-group>
                <award-group id="funding-0009">
                  <funding-source>
                    <institution-wrap>
                      <institution>Helsingin Yliopiston Tiedesäätiö
</institution>
                      <institution-id institution-id-type="doi">10.13039/100007798</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>TYH2016251</award-id>
                  <award-id>TYH2017251</award-id>
                  <award-id>TYH2018229</award-id>
                  <award-id>TYH2019319</award-id>
                  <award-id>Y1014SL017</award-id>
                  <award-id>Y1014SL018</award-id>
                  <award-id>Y1014SULE1</award-id>
                </award-group>
                <award-group id="funding-0010">
                  <funding-source>
                    <institution-wrap>
                      <institution>Suomen Hammaslääkäriseura Apollonia
</institution>
                      <institution-id institution-id-type="doi">10.13039/501100005634</institution-id>
                    </institution-wrap>
                  </funding-source>
                </award-group>
              </funding-group>
              <counts>
                <fig-count count="2"/>
                <table-count count="3"/>
                <page-count count="9"/>
                <word-count count="5847"/>
              </counts>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>source-schema-version-number</meta-name>
                  <meta-value>2.0</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>cover-date</meta-name>
                  <meta-value>December 2022</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>details-of-publishers-convertor</meta-name>
                  <meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.2.3 mode:remove_FC converted:18.12.2022</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <p content-type="self-citation">
                <mixed-citation publication-type="journal" id="cre2638-cit-0044"><string-name><surname>Lähteenmäki</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Tervahartiala</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Räisänen</surname>, <given-names>I. T.</given-names></string-name>, <string-name><surname>Pärnänen</surname>, <given-names>P.</given-names></string-name>, &amp; <string-name><surname>Sorsa</surname>, <given-names>T.</given-names></string-name> (<year>2022</year>). <article-title>Fermented lingonberry juice's effects on active MMP‐8 (aMMP‐8), bleeding on probing (BOP), and visible plaque index (VPI) in dental implants—A clinical pilot mouthwash study</article-title>. <source>Clinical and Experimental Dental Research</source>, <volume>8</volume>, <fpage>1322</fpage>–<lpage>1330</lpage>. <pub-id pub-id-type="doi">10.1002/cre2.638</pub-id>
</mixed-citation>
              </p>
            </notes>
          </front>
          <body>
            <sec id="cre2638-sec-0050">
              <label>1</label>
              <title>INTRODUCTION</title>
              <sec id="cre2638-sec-0060">
                <label>1.1</label>
                <title>Lingonberry</title>
                <p>The positive health effects of berries have been studied in various laboratories and clinical trials (Brown et al., <xref rid="cre2638-bib-0006" ref-type="bibr">2014</xref>; Ek et al., <xref rid="cre2638-bib-0012" ref-type="bibr">2006</xref>; Heyman‐Lindén et al., <xref rid="cre2638-bib-0018" ref-type="bibr">2016</xref>; Nile &amp; Park, <xref rid="cre2638-bib-0024" ref-type="bibr">2014</xref>). Lingonberries (<italic toggle="yes">Vaccinium vitis‐idaea</italic> L.) have a high mineral, vitamin, antioxidant, and polyphenol content. According to certain studies, lingonberry polyphenols appear to have anti‐inflammatory properties (Kivimäki et al., <xref rid="cre2638-bib-0020" ref-type="bibr">2014</xref>; Nile &amp; Park, <xref rid="cre2638-bib-0024" ref-type="bibr">2014</xref>; Yahfoufi et al., <xref rid="cre2638-bib-0042" ref-type="bibr">2018</xref>) and antimicrobial effects (Kylli et al., <xref rid="cre2638-bib-0021" ref-type="bibr">2011</xref>; Tian et al., <xref rid="cre2638-bib-0041" ref-type="bibr">2018</xref>). Fermented lingonberry juice (FLJ) inhibits in vitro <italic toggle="yes">Candida glabrata</italic> stress‐ and energy metabolism‐related intracellular protein expression (Pärnänen et al., <xref rid="cre2638-bib-0027" ref-type="bibr">2017</xref>) and the growth of periodontopathogens <italic toggle="yes">Candida</italic> and <italic toggle="yes">Streptococcus mutans</italic>. Additionally, it reduces dental plaque (visual plaque index, VPI), bleeding on probing (BOP), and active matrix metalloproteinase‐8 (aMMP‐8) levels, as demonstrated in an in vivo human study (Pärnänen et al., <xref rid="cre2638-bib-0028" ref-type="bibr">2019</xref>). FLJ has also been shown to inhibit the activation of procollagenase‐2 (MMP‐8) by <italic toggle="yes">Candida glabrata</italic> cell wall proteases (Pärnänen et al., <xref rid="cre2638-bib-0029" ref-type="bibr">2020</xref>). Despite structural modifications following digestion and fermentation, lingonberry extracts retain their biological activity in vitro (Brown et al., <xref rid="cre2638-bib-0006" ref-type="bibr">2014</xref>).</p>
                <p>Previous studies have shown that polyphenols in the high molecular size fractions of crowberry, blackcurrant, bilberry, and lingonberry juices exert an antiaggregation effect on plaque colonizers in vitro (Riihinen et al., <xref rid="cre2638-bib-0032" ref-type="bibr">2011</xref>). Biofilm formation on dental implant surfaces may be reduced by several treatment modalities (Garaicoa et al., <xref rid="cre2638-bib-0014" ref-type="bibr">2020</xref>). Chlorhexidine (CHX) mouthwash and gels used in oral home care have been evaluated by several studies (Bescos et al., <xref rid="cre2638-bib-0005" ref-type="bibr">2020</xref>; Fiorillo, <xref rid="cre2638-bib-0013" ref-type="bibr">2019</xref>; James et al., <xref rid="cre2638-bib-0019" ref-type="bibr">2017</xref>); however, a range of negative side effects has been reported, including discoloration of teeth, taste disturbance/alteration, and oral mucosa symptoms such as soreness. Compared to CHX mouthwash, FLJ mouthwash has not been reported to exert these side effects.</p>
                <p>There are no previous studies on the effects of lingonberries on dental implants, and because of the versatility and safety of lingonberry polyphenols in reducing oral inflammation and microbial load, FLJ appears to be a promising treatment candidate.</p>
              </sec>
              <sec id="cre2638-sec-0070">
                <label>1.2</label>
                <title>Dental implants, peri‐implant mucositis, and peri‐implantitis</title>
                <p>Dental implants are a common treatment for replacing missing teeth. Dental implants require careful home care as infection and inflammation progress faster in dental implants than in natural teeth, and the treatment of dental mucositis is regarded to be more challenging than that of periodontitis (Golub et al., <xref rid="cre2638-bib-0015" ref-type="bibr">2020</xref>). There is a variety of bacteria and yeasts in the oral cavity that form biofilms on all surfaces in a fluid system, as well as on hard, nonshedding surfaces such as oral implants (Bescos et al., <xref rid="cre2638-bib-0005" ref-type="bibr">2020</xref>; Cortelli et al., <xref rid="cre2638-bib-0009" ref-type="bibr">2013</xref>). Due to the high profusion of bacterial exposure in the mouth, the host tissue responds with a protective mechanism that initially leads to the destruction of soft tissues. This initial inflammation on dental implants is termed peri‐implant mucositis; if it is not diagnosed and treated, it may lead to irreversible inflammation that also extends to the hard tissue and develops into peri‐implantitis (Belibasakis et al., <xref rid="cre2638-bib-0003" ref-type="bibr">2015</xref>; Derks &amp; Tomasi, <xref rid="cre2638-bib-0011" ref-type="bibr">2015</xref>; L. Heitz‐Mayfield &amp; Salvi, <xref rid="cre2638-bib-0016" ref-type="bibr">2018</xref>; L. J. Heitz‐Mayfield, <xref rid="cre2638-bib-0017" ref-type="bibr">2008</xref>; Mikolai et al., <xref rid="cre2638-bib-0023" ref-type="bibr">2020</xref>; F. Schwarz et al., <xref rid="cre2638-bib-0033" ref-type="bibr">2018</xref>). Patient home care combined with early clinical diagnosis is a very important element for implant success and maintenance. Mucositis and initial peri‐implantitis can be effectively treated conservatively.</p>
              </sec>
              <sec id="cre2638-sec-0080">
                <label>1.3</label>
                <title>aMMP‐8 and point‐of‐care testing</title>
                <p>Clinical observations are required for the diagnosis of dental implant tissue health. Traditionally, clinical evaluation is performed by measuring the BOP, implant pocket depth, and by performing X‐ray evaluations (Berglundh et al., <xref rid="cre2638-bib-0004" ref-type="bibr">2018</xref>). However, there is an alternative method with which to assess the condition of the tissues around implants. Biomarker‐based aMMP‐8 point‐of‐care testing (POCT) has been extensively studied and is an accurate and validated method (Alassiri et al., <xref rid="cre2638-bib-0001" ref-type="bibr">2018</xref>; Deng et al., <xref rid="cre2638-bib-0010" ref-type="bibr">2021</xref>; Golub et al., <xref rid="cre2638-bib-0015" ref-type="bibr">2020</xref>; Lähteenmäki et al., <xref rid="cre2638-bib-0022" ref-type="bibr">2020</xref>; Räisänen et al., <xref rid="cre2638-bib-0030" ref-type="bibr">2018</xref>, <xref rid="cre2638-bib-0031" ref-type="bibr">2019</xref>; Sorsa, Alassiri, et al., <xref rid="cre2638-bib-0035" ref-type="bibr">2020</xref>; Ziebolz et al., <xref rid="cre2638-bib-0043" ref-type="bibr">2017</xref>). The aMMP‐8 test can be used to detect active and early collagenolysis in dental implant tissues. aMMP‐8 is a lateral flow peri‐implant chair‐side/POCT technology validated for periodontal/peri‐implant diagnosis and screening. aMMP‐8 has been successfully implemented as a key biomarker of the new periodontitis/peri‐implantitis classification, and currently, only commercially available point‐of‐care oral fluid biomarker tests are implemented in the new classifications (Alassiri et al., <xref rid="cre2638-bib-0001" ref-type="bibr">2018</xref>; Deng et al., <xref rid="cre2638-bib-0010" ref-type="bibr">2021</xref>; Sorsa, Alassiri, et al., <xref rid="cre2638-bib-0035" ref-type="bibr">2020</xref>; Sorsa, Bacigalupo, et al., <xref rid="cre2638-bib-0036" ref-type="bibr">2020</xref>; Sorsa et al., <xref rid="cre2638-bib-0040" ref-type="bibr">2021</xref>). aMMP‐8 POCT is the only Food and Drug Administration (USA) and European Union‐approved peri‐implantitis diagnostic test (Alassiri et al., <xref rid="cre2638-bib-0001" ref-type="bibr">2018</xref>; Al‐Majid et al., <xref rid="cre2638-bib-0002" ref-type="bibr">2018</xref>; Sorsa et al., <xref rid="cre2638-bib-0039" ref-type="bibr">2016</xref>, <xref rid="cre2638-bib-0037" ref-type="bibr">2017</xref>, <xref rid="cre2638-bib-0038" ref-type="bibr">2019</xref>). It is a lateral flow immunoassay that detects elevated aMMP‐8 levels. Its sensitivity is 75%–85%, its specificity is 80%–90%, and it is an alternative and adjunctive diagnostic method (Deng et al., <xref rid="cre2638-bib-0010" ref-type="bibr">2021</xref>; Sorsa, Alassiri, et al., <xref rid="cre2638-bib-0035" ref-type="bibr">2020</xref>; Sorsa et al., <xref rid="cre2638-bib-0040" ref-type="bibr">2021</xref>). Compared to the standard evaluation, it strengthens the diagnostic procedure by accounting for disease activity (Golub et al., <xref rid="cre2638-bib-0015" ref-type="bibr">2020</xref>; Lähteenmäki et al., <xref rid="cre2638-bib-0022" ref-type="bibr">2020</xref>; Sorsa, Alassiri, et al., <xref rid="cre2638-bib-0035" ref-type="bibr">2020</xref>; Sorsa, Bacigalupo, et al., <xref rid="cre2638-bib-0036" ref-type="bibr">2020</xref>). The outcome of the test can be read visually as one (test negative) or two (test positive) lines that emerge in a reading window, similar to the classical point‐of‐care pregnancy test (Figure <xref rid="cre2638-fig-0001" ref-type="fig">1</xref>). The results can also be read quantitatively with a device/reader that provides the quantitative and numerical value of the test in 5–7 min.</p>
                <fig position="float" fig-type="Figure" id="cre2638-fig-0001">
                  <label>Figure 1</label>
                  <caption>
                    <p>Sample strip placements in implant sulci. Photographs of an active matrix metalloproteinase‐8 point‐of‐care sample collection container, peri‐implant sulcular fluid collection strip, and dipstick test with a reading window.</p>
                  </caption>
                  <graphic xlink:href="CRE2-8-1322-g002" position="anchor" id="jats-graphic-1"/>
                </fig>
                <p>This study aimed to evaluate the effects of FLJ, used as a mouthwash, on mucositis inflammation in dental implants. The effects were observed and evaluated by recording VPI, BOP, and aMMP‐8 levels.</p>
              </sec>
            </sec>
            <sec sec-type="materials-and-methods" id="cre2638-sec-0090">
              <label>2</label>
              <title>MATERIALS AND METHODS</title>
              <p>A total of 20 patients (male‐to‐female ratio, 8:12; mean age, 71.7; FLJ group, 75 ± 5.8; control group, 68.3 ± 9.4) were recruited from a private dental clinic (Hammasklinikka Kruunu, Tampere, Finland). Age, smoking habits, and presence of chronic diseases were recorded (Table <xref rid="cre2638-tbl-0001" ref-type="table">1</xref>). The participants were divided into two groups to evaluate the effect of FLJ (Pärnänen, <xref rid="cre2638-bib-0025" ref-type="bibr">2017</xref>; Lingora®, Lingora/Pirjo Pärnänen, Vantaa, Finland) on dental implant attachment tissues through traditional oral clinical investigation methods (BOP and VPI) and an aMMP‐8 chair‐side/POCT. The inclusion criteria were one or more dental implants in the anterior or posterior areas with a screw‐retained crown. The implant brand used was Nobel Biocare® (Nobel Biocare Services AG, Zürich‐Flughafen, Switzerland). The patients underwent maintenance treatment every 6 months. Patients were excluded if they were pregnant, had received antibiotic medications in the last 6 months, or if they had used CHX mouthwash in the last 6 months. No periodontal or peri‐implant treatments were performed at the beginning of or during the trial. The patients used either a manual or an electric toothbrush twice daily. Patients in both were instructed to perform interdental cleaning with interdental brushes approximately once a day using the same toothpaste (Oral‐B Pro‐Expert Professional Protection; Procter &amp; Gamble, Cincinnati, OH, USA) and their normal home care tools for 30 days before, during, and after the lingonberry oral rinse period.</p>
              <table-wrap position="float" id="cre2638-tbl-0001" content-type="Table">
                <label>Table 1</label>
                <caption>
                  <p>General characteristics of the patients by group (<italic toggle="yes">n</italic> = 20)</p>
                </caption>
                <table frame="hsides" rules="groups">
                  <col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/>
                  <col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/>
                  <col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/>
                  <col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/>
                  <thead valign="bottom">
                    <tr style="border-bottom:solid 1px #000000" valign="bottom">
                      <th align="left" valign="bottom" rowspan="1" colspan="1">Characteristic</th>
                      <th align="left" valign="bottom" rowspan="1" colspan="1">FLJ group (<italic toggle="yes">n</italic> = 10)</th>
                      <th align="left" valign="bottom" rowspan="1" colspan="1">Control group (<italic toggle="yes">n</italic> = 10)</th>
                      <th align="left" valign="bottom" rowspan="1" colspan="1"><italic toggle="yes">p</italic> Value</th>
                    </tr>
                  </thead>
                  <tbody valign="top">
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Sex</td>
                      <td valign="top" rowspan="1" colspan="1"/>
                      <td valign="top" rowspan="1" colspan="1"/>
                      <td align="char" char="." rowspan="3" valign="top" colspan="1">.650</td>
                    </tr>
                    <tr>
                      <td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Female</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">5</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">7</td>
                    </tr>
                    <tr>
                      <td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Male</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">5</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">3</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Patient age (years)</td>
                      <td valign="top" rowspan="1" colspan="1"/>
                      <td valign="top" rowspan="1" colspan="1"/>
                      <td align="char" char="." rowspan="3" valign="top" colspan="1">.068</td>
                    </tr>
                    <tr>
                      <td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Mean ± SD</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">75 ± 5.8</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">68.3 ± 9.4</td>
                    </tr>
                    <tr>
                      <td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Min–max</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">68–85</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">56–82</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Smoking</td>
                      <td valign="top" rowspan="1" colspan="1"/>
                      <td valign="top" rowspan="1" colspan="1"/>
                      <td align="char" char="." rowspan="3" valign="top" colspan="1">1.000</td>
                    </tr>
                    <tr>
                      <td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Yes</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">1</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">1</td>
                    </tr>
                    <tr>
                      <td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">No</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">9</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">9</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Diabetes</td>
                      <td valign="top" rowspan="1" colspan="1"/>
                      <td valign="top" rowspan="1" colspan="1"/>
                      <td align="char" char="." rowspan="3" valign="top" colspan="1">1.000</td>
                    </tr>
                    <tr>
                      <td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Yes</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">1</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">1</td>
                    </tr>
                    <tr>
                      <td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">No</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">9</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">9</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Heart disease, <italic toggle="yes">n</italic> (%)</td>
                      <td valign="top" rowspan="1" colspan="1"/>
                      <td valign="top" rowspan="1" colspan="1"/>
                      <td align="char" char="." rowspan="3" valign="top" colspan="1">1.000</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" valign="top" rowspan="1" colspan="1">Yes</td>
                      <td valign="top" rowspan="1" colspan="1">3</td>
                      <td valign="top" rowspan="1" colspan="1">3</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" valign="top" rowspan="1" colspan="1">No</td>
                      <td valign="top" rowspan="1" colspan="1">7</td>
                      <td valign="top" rowspan="1" colspan="1">7</td>
                    </tr>
                  </tbody>
                </table>
                <table-wrap-foot>
                  <fn id="cre2638-tbl1-note-0001">
                    <p><italic toggle="yes">Note</italic>: Fisher's exact test was used for sex, smoking, diabetes, and heart disease and a <italic toggle="yes">t</italic> test was used for patient age.</p>
                  </fn>
                  <fn id="cre2638-tbl1-note-0002">
                    <p>Abbreviation: FLJ, fermented lingonberry juice.</p>
                  </fn>
                </table-wrap-foot>
                <permissions>
                  <copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder>
                </permissions>
              </table-wrap>
              <p>FLJ was used as a mouthwash. Its concentrated, naturally occurring sugars were reduced, and there were no additives. Ten participants (Group 1, FLJ group) used 10 ml of FLJ twice daily (30 s) for 15 days, after which they discontinued the mouthwash for 15 days (washout period). Ten participants (Group 2, control group) did not use mouthwash. According to our previous clinical oral fermented lingonberry mouthwash study, a 15‐day trial length was suitable for this pilot study. The washout period is sufficient as long as the mouthwash period enables observation of the clearance of the treatment effect (Pärnänen et al., <xref rid="cre2638-bib-0028" ref-type="bibr">2019</xref>).</p>
              <p>Oral clinical investigation and diagnoses were performed by one dentist at each time point, including VPI (scale ranging from VPI (0) = <italic toggle="yes">no plaque up to VPI</italic>; (3) = <italic toggle="yes">plaque on all tooth surfaces</italic>). BOP (yes/no) was recorded using a standard millimeter‐graded American Eagle WHO probe (American Eagle Manufacturing Co., New Bern, NC, USA: AEEP23/WHOBX) around the implants. The periodontal and peri‐implant diagnoses of the patients by group (<italic toggle="yes">n</italic>= 20) are shown in Table <xref rid="cre2638-tbl-0002" ref-type="table">2</xref>. Peri‐implant health was defined as the absence of ≥4‐mm probing depths, BOP, erythema, swelling, and suppuration around the implant without radiographic bone loss. Peri‐implant mucositis was defined as the presence of BOP with or without erythema, swelling, and/or suppuration around the implant and without radiographic bone loss. Peri‐implantitis was defined as the presence of ≥4‐mm probing depths and BOP with or without erythema, swelling, and/or suppuration around the implant, together with radiographic bone loss ≥2 mm (Berglundh et al., <xref rid="cre2638-bib-0004" ref-type="bibr">2018</xref>).</p>
              <table-wrap position="float" id="cre2638-tbl-0002" content-type="Table">
                <label>Table 2</label>
                <caption>
                  <p>Periodontal status and peri‐implant diagnoses of the participants and their association as calculated using Fisher's exact test for the FLJ and control groups</p>
                </caption>
                <table frame="hsides" rules="groups">
                  <col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/>
                  <col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/>
                  <col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/>
                  <col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/>
                  <col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/>
                  <thead valign="bottom">
                    <tr style="border-bottom:solid 1px #000000" valign="bottom">
                      <th align="left" valign="bottom" rowspan="1" colspan="1">Characteristics</th>
                      <th align="left" valign="bottom" rowspan="1" colspan="1">Healthy</th>
                      <th align="left" valign="bottom" rowspan="1" colspan="1">Mucositis</th>
                      <th align="left" valign="bottom" rowspan="1" colspan="1">Peri‐implantitis</th>
                      <th align="left" valign="bottom" rowspan="1" colspan="1"><italic toggle="yes">p</italic> Value</th>
                    </tr>
                  </thead>
                  <tbody valign="top">
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">FLJ group</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">0</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">4</td>
                      <td align="left" valign="top" rowspan="1" colspan="1">6</td>
                      <td align="left" rowspan="2" valign="top" colspan="1">.650</td>
                    </tr>
                    <tr>
                      <td valign="top" rowspan="1" colspan="1">Control group</td>
                      <td valign="top" rowspan="1" colspan="1">2</td>
                      <td valign="top" rowspan="1" colspan="1">3</td>
                      <td valign="top" rowspan="1" colspan="1">5</td>
                    </tr>
                  </tbody>
                </table>
                <table-wrap-foot>
                  <fn id="cre2638-tbl2-note-0001">
                    <p><italic toggle="yes">Note</italic>: Peri‐implant health was defined as the absence of ≥4‐mm probing depths, BOP, erythema, and swelling and suppuration around the implant, all without radiographic bone loss. Peri‐implant mucositis was defined as the presence of BOP with or without erythema, swelling, and/or suppuration around the implant and without radiographic bone loss. Peri‐implantitis was defined as the presence of ≥4‐mm probing depths and BOP with or without erythema, swelling, and/or suppuration around the implant, together with radiographic bone loss ≥2 mm (Berglundh et al., <xref rid="cre2638-bib-0004" ref-type="bibr">2018</xref>).</p>
                  </fn>
                  <fn id="cre2638-tbl2-note-0002">
                    <p>Abbreviations: BOP, bleeding on probing; FLJ, fermented lingonberry juice.</p>
                  </fn>
                </table-wrap-foot>
                <permissions>
                  <copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder>
                </permissions>
              </table-wrap>
              <p>At the same time points as above, an additional sulcus fluid rinse was collected for chair‐side aMMP‐8 POC tests (ImplantSafe®/ORALyzer®; Dentognostics, Jena, Germany), as described in the study by Lähteenmäki et al. (<xref rid="cre2638-bib-0022" ref-type="bibr">2020</xref>). aMMP‐8 quantitative online evaluation was performed after 0, 15, and 30 days according to the manufacturer's instructions. The sampling site was prepared by removing excess saliva using a short blast of air and water. A sterile peri‐implant sulcular fluid (PISF) collection test strip was placed in the sulcus at the sampling site using tweezers for 30 s, after which the collection strip was immersed in the elution fluid of the test kit for 5 min. The dipstick test was immersed in the elution fluid for 15 s, and then removed and placed in the compartment of the ORALyzer® reader. After 5 min, the aMMP‐8 level results appeared in the result window of the reader, and at the same time, the qualitative sample analysis was visible from the dipstick: two blue lines identified a positive test (aMMP‐8 level ≥ 20 ng/ml), and one blue line, as the test control, indicated a negative test (aMMP‐8 level ≤ 20 ng/ml). The results of the aMMP‐8 POC/chair‐side enzyme test were documented using a photograph after the test result was visible. The patients were treated at the end of the study period with ultrasonic implant debridement, scaling, and root planning, and an airflow powder protocol (EMS®, EMS, Nyon, Switzerland) by an experienced oral hygienist.</p>
              <p>The study was approved by the ethical committees of the Stockholm Community, Sweden (2016/1410‐31) and Helsinki University Central Hospital, Finland (1271/2019 and 51/13/02/2009). The procedures were undertaken with the understanding and written consent of each subject and according to ethical principles, including the World Medical Association Declaration of Helsinki.</p>
              <sec id="cre2638-sec-0100">
                <label>2.1</label>
                <title>Statistical analysis</title>
                <sec id="cre2638-sec-0110">
                  <label>2.1.1</label>
                  <title>Sample size estimation</title>
                  <p>The sample size was estimated based on a correlation of 0.65 among repeated measures for the mixed design repeated measures analysis of variance (ANOVA). The correlation was estimated to be somewhat high, as patients’ aMMP‐8, VPI, and BOP measurements should be quite consistent across time and as no interference in the form of anti‐infective treatment was planned for patients during their visits to the dental hygienist. A total of 20 patients were required to achieve a power of 80.9% with a medium effect size and a significance level of .05. Thus, with 10 patients in the FLJ group and 10 patients in the control group, there was an 80.9% chance of correctly rejecting the null hypothesis of no significant effect of the interaction.</p>
                  <p>The general patient characteristics are summarized in Table <xref rid="cre2638-tbl-0001" ref-type="table">1</xref>. Differences in categorical and continuous variables between the FLJ and control groups were analyzed using Fisher's exact test and a <italic toggle="yes">t</italic> test, respectively. The effects of the FLJ mouthwash on aMMP‐8 levels, VPI, and BOP were measured in the FLJ and control groups (at baseline, 15 days, and 30 days) (Table <xref rid="cre2638-tbl-0003" ref-type="table">3</xref>). The differences in the mean levels of aMMP‐8, VPI, and BOP were investigated using a mixed‐design repeated‐measures ANOVA analysis (Figure <xref rid="cre2638-fig-0002" ref-type="fig">2</xref>). To adjust for multiple comparisons, the Bonferroni correction was used for pairwise comparisons in the repeated‐measures ANOVA. One patient in the FLJ group had outlier aMMP‐8 (extreme outlier, value above Q3 + 3 × interquartile range [IQR]) and VPI (outlier, value above Q3 + 1.5 × IQR) measurements at the third time point (30 days), which were considered in the statistical calculations (with and without this patient). Statistical significance was defined as a two‐tailed <italic toggle="yes">p</italic> &lt; .05. All statistical calculations were performed using SPSS Statistics version 27 (IBM Corp) for Macintosh and the rstatix package (version 0.6.0) in R statistical software version 3.6.3. Figures were created using JMP Pro version 15 (SAS Institute Inc., Cary, NC, USA) for Macintosh software.</p>
                  <table-wrap position="float" id="cre2638-tbl-0003" content-type="Table">
                    <label>Table 3</label>
                    <caption>
                      <p>Results of intra‐ and intergroup comparisons of aMMP‐8, VPI, and BOP at baseline, after 15 days of mouthwash use, and after a 15‐day washout period</p>
                    </caption>
                    <table frame="hsides" rules="groups">
                      <col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/>
                      <col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/>
                      <col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/>
                      <col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/>
                      <col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/>
                      <col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/>
                      <col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/>
                      <thead valign="bottom">
                        <tr valign="bottom">
                          <th valign="bottom" rowspan="1" colspan="1"/>
                          <th align="left" colspan="3" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Model 1: All patients</th>
                          <th align="left" colspan="3" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Model 2: A patient with outlier values excluded</th>
                        </tr>
                        <tr style="border-bottom:solid 1px #000000" valign="bottom">
                          <th align="left" valign="bottom" rowspan="1" colspan="1">Variable</th>
                          <th align="left" valign="bottom" rowspan="1" colspan="1">Group</th>
                          <th align="left" valign="bottom" rowspan="1" colspan="1">Mean (95% CI)</th>
                          <th align="left" valign="bottom" rowspan="1" colspan="1"><italic toggle="yes">p</italic> Value</th>
                          <th align="left" valign="bottom" rowspan="1" colspan="1">Group</th>
                          <th align="left" valign="bottom" rowspan="1" colspan="1">Mean (95% CI)</th>
                          <th align="left" valign="bottom" rowspan="1" colspan="1"><italic toggle="yes">p</italic> Value</th>
                        </tr>
                      </thead>
                      <tbody valign="top">
                        <tr>
                          <td align="left" rowspan="2" valign="top" colspan="1">aMMP‐8 at baseline</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">FLJ (<italic toggle="yes">n</italic> = 10)</td>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">89.23 (63.19)</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">.888 (Time)</td>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">FLJ (<italic toggle="yes">n</italic> = 9)</td>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">85.32 (34.80–135.83)</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">.341 (Time)</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Control (<italic toggle="yes">n</italic> = 10)</td>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">92.66 (40.00–145.32)</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">.826 (Time × Group)</td>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">Control (<italic toggle="yes">n</italic> = 10)</td>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">92.66 (40.00–145.32)</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">.809 (Time × Group)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="2" valign="top" colspan="1">aMMP‐8 at 15 days</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">FLJ (<italic toggle="yes">n</italic> = 10)</td>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">84.63 (48.86–120.40)</td>
                          <td valign="top" rowspan="1" colspan="1"/>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">FLJ (<italic toggle="yes">n</italic> = 9)</td>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">79.58 (40.95–118.22)</td>
                          <td rowspan="2" valign="top" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Control (<italic toggle="yes">n</italic> = 10)</td>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">100.70 (51.37–150.03)</td>
                          <td valign="top" rowspan="1" colspan="1"/>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">Control (<italic toggle="yes">n</italic> = 10)</td>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">100.70 (51.37–150.03)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="2" valign="top" colspan="1">aMMP‐8 at 30 days</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">FLJ (<italic toggle="yes">n</italic> = 10)</td>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">86.80 (25.85–147.75)</td>
                          <td valign="top" rowspan="1" colspan="1"/>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">FLJ (<italic toggle="yes">n</italic> = 9)</td>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">60.59 (44.52–76.65)</td>
                          <td rowspan="2" valign="top" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Control (<italic toggle="yes">n</italic> = 10)</td>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">84.12 (32.38–135.87)</td>
                          <td valign="top" rowspan="1" colspan="1"/>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">Control (<italic toggle="yes">n</italic> = 10)</td>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">84.12 (32.38–135.87)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="2" valign="top" colspan="1">VPI at baseline</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">FLJ (<italic toggle="yes">n</italic> = 10)</td>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">1.40 (0.90–1.90)</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">.002 (Time)</td>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">FLJ (<italic toggle="yes">n</italic> = 9)</td>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">1.33 (0.79–1.88)</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">.003 (Time)</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Control (<italic toggle="yes">n</italic> = 10)</td>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">1.30 (0.40–2.20)</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">.677 (Time × Group)</td>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">Control (<italic toggle="yes">n</italic> = 10)</td>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">1.30 (0.40–2.20)</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">.584 (Time × Group)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="2" valign="top" colspan="1">VPI at 15 days</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">FLJ (<italic toggle="yes">n</italic> = 10)</td>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">0.60 (0.10–1.10)</td>
                          <td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">t</italic>1–<italic toggle="yes">t</italic>2, <italic toggle="yes">p</italic> = .007</td>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">FLJ (<italic toggle="yes">n</italic> = 9)</td>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">0.56 (0.00–1.11)</td>
                          <td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">t</italic>1–<italic toggle="yes">t</italic>2, <italic toggle="yes">p</italic> = .013</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Control (<italic toggle="yes">n</italic> = 10)</td>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">0.80 (0.06–1.54)</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">Bonferroni</td>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">Control (<italic toggle="yes">n</italic> = 10)</td>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">0.80 (0.06–1.54)</td>
                          <td align="left" valign="top" rowspan="1" colspan="1"><italic toggle="yes">t</italic>1–<italic toggle="yes">t</italic>3, <italic toggle="yes">p</italic> = .026 Bonferroni</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="2" valign="top" colspan="1">VPI at 30 days</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">FLJ (<italic toggle="yes">n</italic> = 10)</td>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">0.90 (0.19–1.61)</td>
                          <td valign="top" rowspan="1" colspan="1"/>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">FLJ (<italic toggle="yes">n</italic> = 9)</td>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">0.67 (0.12–1.21)</td>
                          <td rowspan="2" valign="top" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Control (<italic toggle="yes">n</italic> = 10)</td>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">0.90 (0.11–1.69)</td>
                          <td valign="top" rowspan="1" colspan="1"/>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">Control (<italic toggle="yes">n</italic> = 10)</td>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">0.90 (0.11–1.69)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="2" valign="top" colspan="1">BOP at baseline</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">FLJ (<italic toggle="yes">n</italic> = 10)</td>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">1.00 (1.00–1.00)</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">.378 (Time)</td>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">FLJ (<italic toggle="yes">n</italic> = 9)</td>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">1.00 (1.00–1.00)</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">.339 (Time)</td>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Control (<italic toggle="yes">n</italic> = 10)</td>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">0.60 (0.23–0.97)</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">.378 (Time × Group)</td>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">Control (<italic toggle="yes">n</italic> = 10)</td>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">0.60 (0.23–0.97)</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">.339 (Time × Group)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="2" valign="top" colspan="1">BOP at 15 days</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">FLJ (<italic toggle="yes">n</italic> = 10)</td>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">0.70 (0.35–1.05)</td>
                          <td valign="top" rowspan="1" colspan="1"/>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">FLJ (<italic toggle="yes">n</italic> = 9)</td>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">0.67 (0.28–1.05)</td>
                          <td rowspan="2" valign="top" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Control (<italic toggle="yes">n</italic> = 10)</td>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">0.60 (0.23–0.97)</td>
                          <td valign="top" rowspan="1" colspan="1"/>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">Control (<italic toggle="yes">n</italic> = 10)</td>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">0.60 (0.23–0.97)</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="2" valign="top" colspan="1">BOP at 30 days</td>
                          <td align="left" valign="top" rowspan="1" colspan="1">FLJ (<italic toggle="yes">n</italic> = 10)</td>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">0.70 (0.35–1.05)</td>
                          <td valign="top" rowspan="1" colspan="1"/>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">FLJ (<italic toggle="yes">n</italic> = 9)</td>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">0.67 (0.28–1.05)</td>
                          <td rowspan="2" valign="top" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" valign="top" rowspan="1" colspan="1">Control (<italic toggle="yes">n</italic> = 10)</td>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">0.60 (0.23–0.97)</td>
                          <td valign="top" rowspan="1" colspan="1"/>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">Control (<italic toggle="yes">n</italic> = 10)</td>
                          <td align="char" char="(" valign="top" rowspan="1" colspan="1">0.60 (0.23–0.97)</td>
                        </tr>
                      </tbody>
                    </table>
                    <table-wrap-foot>
                      <fn id="cre2638-tbl3-note-0001">
                        <p><italic toggle="yes">Note</italic>: Model 1 and 2 comparisons: Model 1 represents all patients without outliers; in Model 2, one extreme outlier was excluded.</p>
                      </fn>
                      <fn id="cre2638-tbl3-note-0002">
                        <p>Abbreviations: aMMP‐8, active matrix metalloproteinase 8; BOP, bleeding on probing; CI, confidence interval; FLJ, fermented lingonberry juice; VPI, visible plaque index.</p>
                      </fn>
                    </table-wrap-foot>
                    <permissions>
                      <copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder>
                    </permissions>
                  </table-wrap>
                  <fig position="float" fig-type="Figure" id="cre2638-fig-0002">
                    <label>Figure 2</label>
                    <caption>
                      <p>Boxplots of active matrix metalloprotease‐8 (aMMP‐8, ng/ml), visible plaque index (VPI), and bleeding on probing (BOP) data among patients in the fermented lingonberry juice (FLJ) mouthwash and control groups as well as for both groups together (with and without a patient with outlier values) at three time points (at baseline, 15 days, and 30 days). The line represents the group mean with a 95% confidence interval.</p>
                    </caption>
                    <graphic xlink:href="CRE2-8-1322-g001" position="anchor" id="jats-graphic-3"/>
                  </fig>
                </sec>
              </sec>
            </sec>
            <sec sec-type="results" id="cre2638-sec-0120">
              <label>3</label>
              <title>RESULTS</title>
              <p>The patient characteristics are presented in Table <xref rid="cre2638-tbl-0001" ref-type="table">1</xref>. Fifty percent of the participants in the FLJ group were men, and 30% were men in the control group (<italic toggle="yes">p</italic> = .650). The mean ages of the patients were 75.1 and 68.3 years in the FLJ and control groups, respectively (<italic toggle="yes">p</italic> = .068). There were no significant differences in the prevalence of smoking or comorbidities between the FLJ and control groups.</p>
              <p>The aMMP‐8, VPI, and BOP measurements for the FLJ and control groups are presented in Figure <xref rid="cre2638-fig-0002" ref-type="fig">2</xref>. Positive effects were observed in the FLJ group after the first 15 days when the lingonberry mouthwash was used. There was a decrease in the mean aMMP‐8, VPI, and BOP levels between the first two time points (at baseline and 15 days) in the FLJ group. When one FLJ group patient with outlier values was excluded, the decrease in these three variables (Figure <xref rid="cre2638-fig-0002" ref-type="fig">2</xref>) was more pronounced. Similar results between these two time points were observed for the mean VPI but not for aMMP‐8 or BOP in the control group (Figure <xref rid="cre2638-fig-0002" ref-type="fig">2</xref>). Second, after the second time point, when both groups were not using the lingonberry mouthwash, the decreasing trend in the periodontal parameters was not as positive as it was during the first 15 days (Figure <xref rid="cre2638-fig-0002" ref-type="fig">2</xref>). The mean VPI increased in both groups, but the mean BOP remained unchanged. The effects of the extreme outliers could be seen in the aMMP‐8 and VPI values among the final 15 days in the FLJ group (Figure <xref rid="cre2638-fig-0002" ref-type="fig">2</xref>). When outliers were excluded, the mean aMMP‐8 continued to decrease, whereas the mean VPI was smaller. In the control group, there was a small decrease in the mean aMMP‐8 level after a small increase during the first 15 days.</p>
              <p>The results of the statistical comparisons are presented in Table <xref rid="cre2638-tbl-0003" ref-type="table">3</xref>. However, there was no significant combined effect of time and group on aMMP‐8 (<italic toggle="yes">p</italic> = .826, <italic toggle="yes">n</italic> = 20; <italic toggle="yes">p</italic> = .809, <italic toggle="yes">n</italic> = 19), VPI (<italic toggle="yes">p</italic> = .677, <italic toggle="yes">n</italic> = 20; <italic toggle="yes">p</italic> = .584, <italic toggle="yes">n</italic> = 19), or BOP (<italic toggle="yes">p</italic> = .378, <italic toggle="yes">n</italic> = 20; <italic toggle="yes">p</italic> = .339, <italic toggle="yes">n</italic> = 19). Only the main effect of time was significant for VPI (<italic toggle="yes">p</italic> = .002, <italic toggle="yes">n</italic> = 20; <italic toggle="yes">p</italic> = .003, <italic toggle="yes">n</italic> = 19), which showed a significant difference between the first two time points (at baseline and 15 days; <italic toggle="yes">p</italic> = .007, <italic toggle="yes">n</italic> = 20 and <italic toggle="yes">p</italic> = .013, <italic toggle="yes">n</italic> = 19) and the first and last time points (at baseline and 30 days; <italic toggle="yes">p</italic> = .026, <italic toggle="yes">n</italic> = 19). For aMMP‐8 and BOP, the main effect of time was not significant (<italic toggle="yes">p</italic> = .888, <italic toggle="yes">n</italic> = 20; <italic toggle="yes">p</italic> = .341, <italic toggle="yes">n</italic> = 19; <italic toggle="yes">p</italic> = .378, <italic toggle="yes">n</italic> = 20; <italic toggle="yes">p</italic> = .339, <italic toggle="yes">n</italic> = 19, respectively).</p>
            </sec>
            <sec sec-type="discussion" id="cre2638-sec-0130">
              <label>4</label>
              <title>DISCUSSION</title>
              <p>This study was the first of its kind to examine the effects of FLJ on parameters that reflect the course of peri‐implant health and disease using indices and to additionally assess disease activity using the aMMP‐8 POCT. In the current study, 15 days of using the FLJ mouthwash seemed to have similar decreasing effects on PISF aMMP‐8, visible plaque, and BOP levels around dental implants. In the control group, a similar, although smaller, decrease was seen in visible plaque levels, but not in aMMP‐8 or BOP levels, after the first 15 days. Statistically significant differences in the mean aMMP‐8, VPI, and BOP levels between the FLJ and control groups were not observed in this study. A previous clinical study (Pärnänen et al., <xref rid="cre2638-bib-0028" ref-type="bibr">2019</xref>) demonstrated that FLJ mouthwash decreased whole‐mouth aMMP‐8, BOP, and VPI measured by traditional periodontal techniques in patients with natural teeth. This suggests that the FLJ mouthwash period of only 15 days may have been too short a period of time to achieve site‐specific effects instead of whole‐mouth effects. This is supported by the findings of this study where the differences in aMMP‐8, VPI, and BOP between the groups diminished after the lingonberry regimen ended. Furthermore, exclusion of the effect of outliers revealed that aMMP‐8 levels continued to decrease in the FLJ group, even after discontinuation of the mouthwash regimen. This suggests that the effect of the FLJ mouthwash could be seen earlier in the visible plaque levels, while the antiproteolytic effects lasted longer or were delayed for aMMP‐8 levels that are known to indicate and reflect the risk of ongoing collagenolytic peri‐implant tissue destruction (Lähteenmäki et al., <xref rid="cre2638-bib-0022" ref-type="bibr">2020</xref>; Pärnänen et al., <xref rid="cre2638-bib-0029" ref-type="bibr">2020</xref>).</p>
              <p>There were certain limitations in this study that may explain why the results did not reach statistically significant levels, even though the trend of the parameter values decreased during the FLJ mouthwash study period. Due to the relatively short study period, visits to the dental hygienist may have influenced the results by motivating some study patients in both groups toward better oral hygiene than normal. This might have decreased the difference between the two groups. Therefore, in order to achieve sufficient estimate precision, it seems essential to control for this kind of confounding factor more carefully in future studies with longer study periods and larger sample sizes. However, it is unclear whether the toothpaste used by all patients during the study period had any effect on the results. To our knowledge, there is no clear evidence in the literature demonstrating that toothpaste exhibits scientifically relevant oral anti‐inflammatory actions. As expected, the participants used toothpaste during the FLJ and washout periods. Thus, the potential antimicrobial and anti‐biofilm effects of the toothpaste remained a constant factor between both groups in this study, which did not cause confounding between the groups. It is worth noting that toothpaste is part of the recommended oral hygiene regime worldwide, making it difficult to exclude its potential anti‐inflammatory effects in study designs.</p>
              <p>The treatment of peri‐implant mucositis, especially peri‐implantitis, is challenging. The current study was a clinical pilot study to evaluate the effects of a natural substance as an alternative adjunctive therapy for these conditions. Further studies with larger patient cohorts and significantly longer study periods are required to verify and extend the results of the present study. FLJ appears to be a promising and safe aid in oral home care for reducing plaque levels, gingival bleeding, and inflammation around dental implants and throughout the mouth. Lingonberries are known to have anti‐inflammatory, antioxidant (radical oxygen scavenging), antiproteolytic, and antimicrobial properties (Pärnänen et al., <xref rid="cre2638-bib-0026" ref-type="bibr">2021</xref>). FLJ does not inhibit <italic toggle="yes">Lactobacilli</italic> growth, and according to Cereda et al. (<xref rid="cre2638-bib-0007" ref-type="bibr">2018</xref>), probiotic <italic toggle="yes">Lactobacilli</italic> have also been proposed to have beneficial effects on chemoradiotherapy‐related oral mucositis and peri‐implant mucositis. Currently, CHX is regarded as the gold standard for the treatment of oral and implant‐related infections. However, there are indications that repeated exposure to the most commonly used antiseptics, such as CHX, may induce resistance to oral bacteria in deep biofilms, which has never been demonstrated for lingonberries (S. R. Schwarz et al., <xref rid="cre2638-bib-0034" ref-type="bibr">2021</xref>).</p>
            </sec>
            <sec sec-type="conclusions" id="cre2638-sec-0140">
              <label>5</label>
              <title>CONCLUSION</title>
              <p>This study was the first of its kind to examine the effects of FLJ on the parameters that reflect dental implant health and disease using indices and to additionally assess the collagenase activity in PISF using the aMMP‐8 POCT. aMMP‐8 values reflect early and developing collagenolytic inflammation in the oral cavity. When analyzed in the PISF, these values are exact site‐specific indicators and biomarkers of the progression of peri‐implantitis and may be used to monitor the oral effects of FLJ. The continuous reductions in the amount of plaque, aMMP‐8, and BOP by FLJ rinsing were promising, considering the relatively short study period. This pilot study provides a promising basis for large‐scale studies with significantly longer study periods to verify and extend these results in the future.</p>
            </sec>
            <sec id="cre2638-sec-0150">
              <title>AUTHOR CONTRIBUTIONS</title>
              <p>Hanna Lähteenmäki performed the clinical examinations and sample gathering. Ismo T. Räisänen and Hanna Lähteenmäki performed statistical analyses. All authors contributed to the study design, writing, and manuscript review.</p>
            </sec>
            <sec sec-type="COI-statement" id="cre2638-sec-0170">
              <title>CONFLICTS OF INTEREST</title>
              <p>Prof. Timo Sorsa is the inventor of US patents 5652223, 5736341, 5866432, 6143476, 20170023571A1 (Grant no. 6.6.2019), WO 2018/060553A1 (Grant no. 31.5.2018), a coinventor of the 10488415 B2 patent, the Japanese patent 2016‐554676, and the South Korean patent 10‐2016‐7025378. Dr. Pirjo Pärnänen is the inventor of patent EP 2585087B1 and the holder of the trademark Lingora®.</p>
            </sec>
          </body>
          <back>
            <ack id="cre2638-sec-0160">
              <title>ACKNOWLEDGMENTS</title>
              <p>This work was supported by grants from the University of Helsinki Research Foundation (TYH2016251, TYH2017251, TYH2018229, TYH2019319, Y1014SL017, Y1014SL018, and Y1014SULE1), Finland; Karolinska Institute, Stockholm, Sweden; the Finnish Dental Society Apollonia; the Minerva Foundation Selma and Maja‐Lisa Selander's Fund; the Yrjö Jahnsson Foundation sr; the Paulo Foundation; the Emil Aaltonen Foundation sr; the Juhani Aho Foundation for Medical Research sr; the Orion Research Foundation; and Helsingin Seudun Hammaslääkärit r.y. (Dentists of Helsinki Region Association), Finland.</p>
            </ack>
            <sec sec-type="data-availability" id="cre2638-sec-0190">
              <title>DATA AVAILABILITY STATEMENT</title>
              <p>The data that support the findings of this study are available from the corresponding author upon reasonable request.</p>
            </sec>
            <ref-list content-type="cited-references" id="cre2638-bibl-0001">
              <title>REFERENCES</title>
              <ref id="cre2638-bib-0001">
                <mixed-citation publication-type="journal" id="cre2638-cit-0001"><string-name><surname>Alassiri</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Parnanen</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Rathnayake</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Johannsen</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Heikkinen</surname>, <given-names>A. M.</given-names></string-name>, <string-name><surname>Lazzara</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>van der Schoor</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>van der Schoor</surname>, <given-names>J. G.</given-names></string-name>, <string-name><surname>Tervahartiala</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Gieselmann</surname>, <given-names>D.</given-names></string-name>, &amp; <string-name><surname>Sorsa</surname>, <given-names>T.</given-names></string-name> (<year>2018</year>). <article-title>The ability of quantitative, specific, and sensitive point‐of‐care/chair‐side oral fluid immunotests for aMMP‐8 to detect periodontal and peri‐implant diseases</article-title>. <source>Disease Markers</source>, <volume>2018</volume>, <elocation-id>1306396</elocation-id>. <pub-id pub-id-type="doi">10.1155/2018/1306396</pub-id>
<pub-id pub-id-type="pmid">30154936</pub-id></mixed-citation>
              </ref>
              <ref id="cre2638-bib-0002">
                <mixed-citation publication-type="journal" id="cre2638-cit-0002"><string-name><surname>Al‐Majid</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Alassiri</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Rathnayake</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Tervahartiala</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Gieselmann</surname>, <given-names>D. R.</given-names></string-name>, &amp; <string-name><surname>Sorsa</surname>, <given-names>T.</given-names></string-name> (<year>2018</year>). <article-title>Matrix metalloproteinase‐8 as an inflammatory and prevention biomarker in periodontal and peri‐implant diseases</article-title>. <source>International Journal of Dentistry</source>, <volume>2018</volume>, <elocation-id>7891323</elocation-id>. <pub-id pub-id-type="doi">10.1155/2018/7891323</pub-id>
<pub-id pub-id-type="pmid">30305812</pub-id></mixed-citation>
              </ref>
              <ref id="cre2638-bib-0003">
                <mixed-citation publication-type="journal" id="cre2638-cit-0003"><string-name><surname>Belibasakis</surname>, <given-names>G. N.</given-names></string-name>, <string-name><surname>Charalampakis</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Bostanci</surname>, <given-names>N.</given-names></string-name>, &amp; <string-name><surname>Stadlinger</surname>, <given-names>B.</given-names></string-name> (<year>2015</year>). <article-title>Peri‐implant infections of oral biofilm etiology</article-title>. <source>Advances in Experimental Medicine and Biology</source>, <volume>830</volume>, <fpage>69</fpage>–<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1007/978-3-319-11038-7_4</pub-id>
<pub-id pub-id-type="pmid">25366221</pub-id></mixed-citation>
              </ref>
              <ref id="cre2638-bib-0004">
                <mixed-citation publication-type="journal" id="cre2638-cit-0004"><string-name><surname>Berglundh</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Armitage</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Araujo</surname>, <given-names>M. G.</given-names></string-name>, <string-name><surname>Avila‐Ortiz</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Blanco</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Camargo</surname>, <given-names>P. M.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Cochran</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Derks</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Figuero</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Hämmerle</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Heitz‐Mayfield</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Huynh‐Ba</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Iacono</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Koo</surname>, <given-names>K. T.</given-names></string-name>, <string-name><surname>Lambert</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>McCauley</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Quirynen</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Renvert</surname>, <given-names>S.</given-names></string-name>, … <string-name><surname>Zitzmann</surname>, <given-names>N.</given-names></string-name> (<year>2018</year>). <article-title>Peri‐implant diseases and conditions: Consensus report of workgroup 4 of the 2017 World Workshop on the Classification of Periodontal and Peri‐Implant Diseases and Conditions</article-title>. <source>Journal of Periodontology</source>, <volume>89</volume>(<issue>Suppl 1</issue>), <fpage>S313</fpage>–<lpage>S318</lpage>. <pub-id pub-id-type="doi">10.1002/JPER.17-0739</pub-id>
<pub-id pub-id-type="pmid">29926955</pub-id></mixed-citation>
              </ref>
              <ref id="cre2638-bib-0005">
                <mixed-citation publication-type="journal" id="cre2638-cit-0005"><string-name><surname>Bescos</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Ashworth</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Cutler</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Brookes</surname>, <given-names>Z. L.</given-names></string-name>, <string-name><surname>Belfield</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Rodiles</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Casas‐Agustench</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Farnham</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Liddle</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Burleigh</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>White</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Easton</surname>, <given-names>C.</given-names></string-name>, &amp; <string-name><surname>Hickson</surname>, <given-names>M.</given-names></string-name> (<year>2020</year>). <article-title>Effects of chlorhexidine mouthwash on the oral microbiome</article-title>. <source>Scientific Reports</source>, <volume>10</volume>(<issue>1</issue>), <fpage>5254</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-020-61912-4</pub-id>
<pub-id pub-id-type="pmid">32210245</pub-id></mixed-citation>
              </ref>
              <ref id="cre2638-bib-0006">
                <mixed-citation publication-type="journal" id="cre2638-cit-0006"><string-name><surname>Brown</surname>, <given-names>E. M.</given-names></string-name>, <string-name><surname>Nitecki</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Pereira‐Caro</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>McDougall</surname>, <given-names>G. J.</given-names></string-name>, <string-name><surname>Stewart</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Rowland</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Crozier</surname>, <given-names>A.</given-names></string-name>, &amp; <string-name><surname>Gill</surname>, <given-names>C. I.</given-names></string-name> (<year>2014</year>). <article-title>Comparison of in vivo and in vitro digestion on polyphenol composition in lingonberries: Potential impact on colonic health</article-title>. <source>BioFactors (Oxford, England)</source>, <volume>40</volume>(<issue>6</issue>), <fpage>611</fpage>–<lpage>623</lpage>. <pub-id pub-id-type="doi">10.1002/biof.1173</pub-id>
<pub-id pub-id-type="pmid">25359330</pub-id></mixed-citation>
              </ref>
              <ref id="cre2638-bib-0007">
                <mixed-citation publication-type="journal" id="cre2638-cit-0007"><string-name><surname>Cereda</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Caraccia</surname>, <given-names>M.</given-names></string-name>, &amp; <string-name><surname>Caccialanza</surname>, <given-names>R.</given-names></string-name> (<year>2018</year>). <article-title>Probiotics and mucositis</article-title>. <source>Current Opinion in Clinical Nutrition and Metabolic Care</source>, <volume>21</volume>(<issue>5</issue>), <fpage>399</fpage>–<lpage>404</lpage>. <pub-id pub-id-type="doi">10.1097/MCO.0000000000000487</pub-id>
<pub-id pub-id-type="pmid">29916923</pub-id></mixed-citation>
              </ref>
              <ref id="cre2638-bib-0009">
                <mixed-citation publication-type="journal" id="cre2638-cit-0009"><string-name><surname>Cortelli</surname>, <given-names>S. C.</given-names></string-name>, <string-name><surname>Cortelli</surname>, <given-names>J. R.</given-names></string-name>, <string-name><surname>Romeiro</surname>, <given-names>R. L.</given-names></string-name>, <string-name><surname>Costa</surname>, <given-names>F. O.</given-names></string-name>, <string-name><surname>Aquino</surname>, <given-names>D. R.</given-names></string-name>, <string-name><surname>Orzechowski</surname>, <given-names>P. R.</given-names></string-name>, <string-name><surname>Araújo</surname>, <given-names>V. C.</given-names></string-name>, &amp; <string-name><surname>Duarte</surname>, <given-names>P. M.</given-names></string-name> (<year>2013</year>). <article-title>Frequency of periodontal pathogens in equivalent peri‐implant and periodontal clinical statuses</article-title>. <source>Archives of Oral Biology</source>, <volume>58</volume>(<issue>1</issue>), <fpage>67</fpage>–<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1016/j.archoralbio.2012.09.004</pub-id>
<pub-id pub-id-type="pmid">23127822</pub-id></mixed-citation>
              </ref>
              <ref id="cre2638-bib-0010">
                <mixed-citation publication-type="journal" id="cre2638-cit-0010"><string-name><surname>Deng</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Pelekos</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Jin</surname>, <given-names>L.</given-names></string-name>, &amp; <string-name><surname>Tonetti</surname>, <given-names>M. S.</given-names></string-name> (<year>2021</year>). <article-title>Diagnostic accuracy of a point‐of‐care aMMP‐8 test in the discrimination of periodontal health and disease</article-title>. <source>Journal of Clinical Periodontology</source>, <volume>48</volume>(<issue>8</issue>), <fpage>1051</fpage>–<lpage>1065</lpage>. <pub-id pub-id-type="doi">10.1111/jcpe.13485</pub-id>
<pub-id pub-id-type="pmid">33998040</pub-id></mixed-citation>
              </ref>
              <ref id="cre2638-bib-0011">
                <mixed-citation publication-type="journal" id="cre2638-cit-0011"><string-name><surname>Derks</surname>, <given-names>J.</given-names></string-name>, &amp; <string-name><surname>Tomasi</surname>, <given-names>C.</given-names></string-name> (<year>2015</year>). <article-title>Peri‐implant health and disease. A systematic review of current epidemiology</article-title>. <source>Journal of Clinical Periodontology</source>, <volume>42</volume>(<issue>Suppl 16</issue>), <fpage>S158</fpage>–<lpage>S171</lpage>. <pub-id pub-id-type="doi">10.1111/jcpe.12334</pub-id>
<pub-id pub-id-type="pmid">25495683</pub-id></mixed-citation>
              </ref>
              <ref id="cre2638-bib-0012">
                <mixed-citation publication-type="journal" id="cre2638-cit-0012"><string-name><surname>Ek</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Kartimo</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Mattila</surname>, <given-names>S.</given-names></string-name>, &amp; <string-name><surname>Tolonen</surname>, <given-names>A.</given-names></string-name> (<year>2006</year>). <article-title>Characterization of phenolic compounds from lingonberry (<italic toggle="yes">Vaccinium vitis‐idaea</italic>)</article-title>. <source>Journal of Agricultural and Food Chemistry</source>, <volume>54</volume>(<issue>26</issue>), <fpage>9834</fpage>–<lpage>9842</lpage>. <pub-id pub-id-type="doi">10.1021/jf0623687</pub-id>
<pub-id pub-id-type="pmid">17177509</pub-id></mixed-citation>
              </ref>
              <ref id="cre2638-bib-0013">
                <mixed-citation publication-type="journal" id="cre2638-cit-0013"><string-name><surname>Fiorillo</surname>, <given-names>L.</given-names></string-name> (<year>2019</year>). <article-title>Chlorhexidine gel use in the oral district: A systematic review</article-title>. <source>Gels (Basel, Switzerland)</source>, <volume>5</volume>(<issue>2</issue>), <elocation-id>31</elocation-id>. <pub-id pub-id-type="doi">10.3390/gels5020031</pub-id>
<pub-id pub-id-type="pmid">31212600</pub-id></mixed-citation>
              </ref>
              <ref id="cre2638-bib-0014">
                <mixed-citation publication-type="journal" id="cre2638-cit-0014"><string-name><surname>Garaicoa</surname>, <given-names>J. L.</given-names></string-name>, <string-name><surname>Bates</surname>, <given-names>A. M.</given-names></string-name>, <string-name><surname>Avila‐Ortiz</surname>, <given-names>G.</given-names></string-name>, &amp; <string-name><surname>Brogden</surname>, <given-names>K. A.</given-names></string-name> (<year>2020</year>). <article-title>Antimicrobial prosthetic surfaces in the oral cavity—A perspective on creative approaches</article-title>. <source>Microorganisms</source>, <volume>8</volume>(<issue>8</issue>), <elocation-id>1247</elocation-id>. <pub-id pub-id-type="doi">10.3390/microorganisms8081247</pub-id>
<pub-id pub-id-type="pmid">32824437</pub-id></mixed-citation>
              </ref>
              <ref id="cre2638-bib-0015">
                <mixed-citation publication-type="journal" id="cre2638-cit-0015"><string-name><surname>Golub</surname>, <given-names>L. M.</given-names></string-name>, <string-name><surname>Räisänen</surname>, <given-names>I. T.</given-names></string-name>, <string-name><surname>Sorsa</surname>, <given-names>T.</given-names></string-name>, &amp; <string-name><surname>Preshaw</surname>, <given-names>P. M.</given-names></string-name> (<year>2020</year>). <article-title>An unexplored pharmacologic/diagnostic strategy for peri‐implantitis: A protocol proposal</article-title>. <source>Diagnostics (Basel, Switzerland)</source>, <volume>10</volume>(<issue>12</issue>), <elocation-id>1050</elocation-id>. <pub-id pub-id-type="doi">10.3390/diagnostics10121050</pub-id>
<pub-id pub-id-type="pmid">33291429</pub-id></mixed-citation>
              </ref>
              <ref id="cre2638-bib-0016">
                <mixed-citation publication-type="journal" id="cre2638-cit-0016"><string-name><surname>Heitz‐Mayfield</surname>, <given-names>L.</given-names></string-name>, &amp; <string-name><surname>Salvi</surname>, <given-names>G. E.</given-names></string-name> (<year>2018</year>). <article-title>Peri‐implant mucositis</article-title>. <source>Journal of Clinical Periodontology</source>, <volume>45</volume>(<issue>Suppl 20</issue>), <fpage>S237</fpage>–<lpage>S245</lpage>. <pub-id pub-id-type="doi">10.1111/jcpe.12953</pub-id>
<pub-id pub-id-type="pmid">29926488</pub-id></mixed-citation>
              </ref>
              <ref id="cre2638-bib-0017">
                <mixed-citation publication-type="journal" id="cre2638-cit-0017"><string-name><surname>Heitz‐Mayfield</surname>, <given-names>L. J.</given-names></string-name> (<year>2008</year>). <article-title>Peri‐implant diseases: Diagnosis and risk indicators</article-title>. <source>Journal of Clinical Periodontology</source>, <volume>35</volume>(<issue>8, Suppl</issue>), <fpage>292</fpage>–<lpage>304</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-051X.2008.01275.x</pub-id>
<pub-id pub-id-type="pmid">18724857</pub-id></mixed-citation>
              </ref>
              <ref id="cre2638-bib-0018">
                <mixed-citation publication-type="journal" id="cre2638-cit-0018"><string-name><surname>Heyman‐Lindén</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Kotowska</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Sand</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Bjursell</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Plaza</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Turner</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Holm</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Fåk</surname>, <given-names>F.</given-names></string-name>, &amp; <string-name><surname>Berger</surname>, <given-names>K.</given-names></string-name> (<year>2016</year>). <article-title>Lingonberries alter the gut microbiota and prevent low‐grade inflammation in high‐fat diet fed mice</article-title>. <source>Food &amp; Nutrition Research</source>, <volume>60</volume>, <elocation-id>29993</elocation-id>. <pub-id pub-id-type="doi">10.3402/fnr.v60.29993</pub-id>
<pub-id pub-id-type="pmid">27125264</pub-id></mixed-citation>
              </ref>
              <ref id="cre2638-bib-0019">
                <mixed-citation publication-type="journal" id="cre2638-cit-0019"><string-name><surname>James</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Worthington</surname>, <given-names>H. V.</given-names></string-name>, <string-name><surname>Parnell</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Harding</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Lamont</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Cheung</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Whelton</surname>, <given-names>H.</given-names></string-name>, &amp; <string-name><surname>Riley</surname>, <given-names>P.</given-names></string-name> (<year>2017</year>). <article-title>Chlorhexidine mouthrinse as an adjunctive treatment for gingival health</article-title>. <source>The Cochrane Database of Systematic Reviews</source>, <volume>3</volume>(<issue>3</issue>), <elocation-id>CD008676</elocation-id>. <pub-id pub-id-type="doi">10.1002/14651858.CD008676.pub2</pub-id>
<pub-id pub-id-type="pmid">28362061</pub-id></mixed-citation>
              </ref>
              <ref id="cre2638-bib-0020">
                <mixed-citation publication-type="journal" id="cre2638-cit-0020"><string-name><surname>Kivimäki</surname>, <given-names>A. S.</given-names></string-name>, <string-name><surname>Siltari</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Ehlers</surname>, <given-names>P. I.</given-names></string-name>, <string-name><surname>Korpela</surname>, <given-names>R.</given-names></string-name>, &amp; <string-name><surname>Vapaatalo</surname>, <given-names>H.</given-names></string-name> (<year>2014</year>). <article-title>Lingonberry juice negates the effects of a high salt diet on vascular function and low‐grade inflammation</article-title>. <source>Journal of Functional Foods</source>, <volume>7</volume>, <fpage>238</fpage>–<lpage>245</lpage>. <pub-id pub-id-type="doi">10.1016/j.jff.2014.02.005</pub-id>
</mixed-citation>
              </ref>
              <ref id="cre2638-bib-0021">
                <mixed-citation publication-type="journal" id="cre2638-cit-0021"><string-name><surname>Kylli</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Nohynek</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Puupponen‐Pimiä</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Westerlund‐Wikström</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Leppänen</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Welling</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Moilanen</surname>, <given-names>E.</given-names></string-name>, &amp; <string-name><surname>Heinonen</surname>, <given-names>M.</given-names></string-name> (<year>2011</year>). <article-title>Lingonberry (<italic toggle="yes">Vaccinium vitis‐idaea</italic>) and European cranberry (<italic toggle="yes">Vaccinium microcarpon</italic>) proanthocyanidins: Isolation, identification, and bioactivities</article-title>. <source>Journal of Agricultural and Food Chemistry</source>, <volume>59</volume>(<issue>7</issue>), <fpage>3373</fpage>–<lpage>3384</lpage>. <pub-id pub-id-type="doi">10.1021/jf104621e</pub-id>
<pub-id pub-id-type="pmid">21370878</pub-id></mixed-citation>
              </ref>
              <ref id="cre2638-bib-0022">
                <mixed-citation publication-type="journal" id="cre2638-cit-0022"><string-name><surname>Lähteenmäki</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Umeizudike</surname>, <given-names>K. A.</given-names></string-name>, <string-name><surname>Heikkinen</surname>, <given-names>A. M.</given-names></string-name>, <string-name><surname>Räisänen</surname>, <given-names>I. T.</given-names></string-name>, <string-name><surname>Rathnayake</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Johannsen</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Tervahartiala</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Nwhator</surname>, <given-names>S. O.</given-names></string-name>, &amp; <string-name><surname>Sorsa</surname>, <given-names>T.</given-names></string-name> (<year>2020</year>). <article-title>aMMP‐8 point‐of‐care/chairside oral fluid technology as a rapid, non‐invasive tool for periodontitis and peri‐implantitis screening in a medical care setting</article-title>. <source>Diagnostics (Basel, Switzerland)</source>, <volume>10</volume>(<issue>8</issue>), <elocation-id>562</elocation-id>. <pub-id pub-id-type="doi">10.3390/diagnostics10080562</pub-id>
<pub-id pub-id-type="pmid">32764436</pub-id></mixed-citation>
              </ref>
              <ref id="cre2638-bib-0023">
                <mixed-citation publication-type="journal" id="cre2638-cit-0023"><string-name><surname>Mikolai</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Kommerein</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Ingendoh‐Tsakmakidis</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Winkel</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Falk</surname>, <given-names>C. S.</given-names></string-name>, &amp; <string-name><surname>Stiesch</surname>, <given-names>M.</given-names></string-name> (<year>2020</year>). <article-title>Early host‐microbe interaction in a peri‐implant oral mucosa‐biofilm model</article-title>. <source>Cellular Microbiology</source>, <volume>22</volume>(<issue>8</issue>), <elocation-id>e13209</elocation-id>. <pub-id pub-id-type="doi">10.1111/cmi.13209</pub-id>
<pub-id pub-id-type="pmid">32329166</pub-id></mixed-citation>
              </ref>
              <ref id="cre2638-bib-0024">
                <mixed-citation publication-type="journal" id="cre2638-cit-0024"><string-name><surname>Nile</surname>, <given-names>S. H.</given-names></string-name>, &amp; <string-name><surname>Park</surname>, <given-names>S. W.</given-names></string-name> (<year>2014</year>). <article-title>Edible berries: Bioactive components and their effect on human health</article-title>. <source>Nutrition (Burbank, Los Angeles County, Calif.)</source>, <volume>30</volume>(<issue>2</issue>), <fpage>134</fpage>–<lpage>144</lpage>. <pub-id pub-id-type="doi">10.1016/j.nut.2013.04.007</pub-id>
<pub-id pub-id-type="pmid">24012283</pub-id></mixed-citation>
              </ref>
              <ref id="cre2638-bib-0025">
                <mixed-citation publication-type="miscellaneous" id="cre2638-cit-0025"><string-name><surname>Pärnänen</surname>, <given-names>P.</given-names></string-name> (<year>2017</year>). <italic toggle="yes">A preparation for balancing the composition of the oral microbial flora</italic> (Europatent 2585087 B1).</mixed-citation>
              </ref>
              <ref id="cre2638-bib-0026">
                <mixed-citation publication-type="journal" id="cre2638-cit-0026"><string-name><surname>Pärnänen</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Lähteenmäki</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Tervahartiala</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Räisänen</surname>, <given-names>I. T.</given-names></string-name>, &amp; <string-name><surname>Sorsa</surname>, <given-names>T.</given-names></string-name> (<year>2021</year>). <article-title>Lingonberries‐General and oral effects on the microbiome and inflammation</article-title>. <source>Nutrients</source>, <volume>13</volume>, <elocation-id>3738</elocation-id>. <pub-id pub-id-type="doi">10.3390/nu13113738</pub-id>
<pub-id pub-id-type="pmid">34835994</pub-id></mixed-citation>
              </ref>
              <ref id="cre2638-bib-0027">
                <mixed-citation publication-type="journal" id="cre2638-cit-0027"><string-name><surname>Pärnänen</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Nawaz</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Sorsa</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Meurman</surname>, <given-names>J.</given-names></string-name>, &amp; <string-name><surname>Nikula‐Ijäs</surname>, <given-names>P.</given-names></string-name> (<year>2017</year>). <article-title>The effect of fermented lingonberry juice on <italic toggle="yes">Candida glabrata</italic> intracellular protein expression</article-title>. <source>International Journal of Dentistry</source>, <volume>2017</volume>, <elocation-id>6185395</elocation-id>. <pub-id pub-id-type="doi">10.1155/2017/6185395</pub-id>
<pub-id pub-id-type="pmid">28465686</pub-id></mixed-citation>
              </ref>
              <ref id="cre2638-bib-0028">
                <mixed-citation publication-type="journal" id="cre2638-cit-0028"><string-name><surname>Pärnänen</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Nikula‐Ijäs</surname>, <given-names>P.</given-names></string-name>, &amp; <string-name><surname>Sorsa</surname>, <given-names>T.</given-names></string-name> (<year>2019</year>). <article-title>Antimicrobial and anti‐inflammatory lingonberry mouthwash—A clinical pilot study in the oral cavity</article-title>. <source>Microorganisms</source>, <volume>7</volume>(<issue>9</issue>), <elocation-id>331</elocation-id>. <pub-id pub-id-type="doi">10.3390/microorganisms7090331</pub-id>
<pub-id pub-id-type="pmid">31500385</pub-id></mixed-citation>
              </ref>
              <ref id="cre2638-bib-0029">
                <mixed-citation publication-type="journal" id="cre2638-cit-0029"><string-name><surname>Pärnänen</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Sorsa</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Tervahartiala</surname>, <given-names>T.</given-names></string-name>, &amp; <string-name><surname>Nikula‐Ijäs</surname>, <given-names>P.</given-names></string-name> (<year>2020</year>). <article-title>Isolation, characterization and regulation of moonlighting proteases from <italic toggle="yes">Candida glabrata</italic> cell wall</article-title>. <source>Microbial Pathogenesis</source>, <volume>149</volume>, <elocation-id>104547</elocation-id>. <pub-id pub-id-type="doi">10.1016/j.micpath.2020.104547</pub-id>
<pub-id pub-id-type="pmid">33010365</pub-id></mixed-citation>
              </ref>
              <ref id="cre2638-bib-0030">
                <mixed-citation publication-type="journal" id="cre2638-cit-0030"><string-name><surname>Räisänen</surname>, <given-names>I. T.</given-names></string-name>, <string-name><surname>Heikkinen</surname>, <given-names>A. M.</given-names></string-name>, <string-name><surname>Siren</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Tervahartiala</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Gieselmann</surname>, <given-names>D. R.</given-names></string-name>, <string-name><surname>van der Schoor</surname>, <given-names>G. J.</given-names></string-name>, <string-name><surname>van der Schoor</surname>, <given-names>P.</given-names></string-name>, &amp; <string-name><surname>Sorsa</surname>, <given-names>T.</given-names></string-name> (<year>2018</year>). <article-title>Point‐of‐care/chairside aMMP‐8 analytics of periodontal diseases' activity and episodic progression</article-title>. <source>Diagnostics (Basel, Switzerland)</source>, <volume>8</volume>(<issue>4</issue>), <elocation-id>74</elocation-id>. <pub-id pub-id-type="doi">10.3390/diagnostics8040074</pub-id>
<pub-id pub-id-type="pmid">30360358</pub-id></mixed-citation>
              </ref>
              <ref id="cre2638-bib-0031">
                <mixed-citation publication-type="journal" id="cre2638-cit-0031"><string-name><surname>Räisänen</surname>, <given-names>I. T.</given-names></string-name>, <string-name><surname>Sorsa</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>van der Schoor</surname>, <given-names>G. J.</given-names></string-name>, <string-name><surname>Tervahartiala</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>van der Schoor</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Gieselmann</surname>, <given-names>D. R.</given-names></string-name>, &amp; <string-name><surname>Heikkinen</surname>, <given-names>A. M.</given-names></string-name> (<year>2019</year>). <article-title>Active matrix metalloproteinase‐8 point‐of‐care (PoC)/chairside mouthrinse test vs. bleeding on probing in diagnosing subclinical periodontitis in adolescents</article-title>. <source>Diagnostics (Basel, Switzerland)</source>, <volume>9</volume>(<issue>1</issue>), <elocation-id>34</elocation-id>. <pub-id pub-id-type="doi">10.3390/diagnostics901003.4</pub-id>
<pub-id pub-id-type="pmid">30909530</pub-id></mixed-citation>
              </ref>
              <ref id="cre2638-bib-0032">
                <mixed-citation publication-type="journal" id="cre2638-cit-0032"><string-name><surname>Riihinen</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Ryynänen</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Toivanen</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Könönen</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Törrönen</surname>, <given-names>R.</given-names></string-name>, &amp; <string-name><surname>Tikkanen‐Kaukanen</surname>, <given-names>C.</given-names></string-name> (<year>2011</year>). <article-title>Antiaggregation potential of berry fractions against pairs of <italic toggle="yes">Streptococcus mutans</italic> with <italic toggle="yes">Fusobacterium nucleatum</italic> or <italic toggle="yes">Actinomyces naeslundii</italic>
</article-title>. <source>Phytotherapy Research</source>, <volume>25</volume>(<issue>1</issue>), <fpage>81</fpage>–<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1002/ptr.3228</pub-id>
<pub-id pub-id-type="pmid">20623601</pub-id></mixed-citation>
              </ref>
              <ref id="cre2638-bib-0033">
                <mixed-citation publication-type="journal" id="cre2638-cit-0033"><string-name><surname>Schwarz</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Derks</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Monje</surname>, <given-names>A.</given-names></string-name>, &amp; <string-name><surname>Wang</surname>, <given-names>H. L.</given-names></string-name> (<year>2018</year>). <article-title>Peri‐implantitis</article-title>. <source>Journal of Periodontology</source>, <volume>89</volume>(<issue>Suppl 1</issue>), <fpage>S267</fpage>–<lpage>S290</lpage>. <pub-id pub-id-type="doi">10.1002/JPER.16-0350</pub-id>
<pub-id pub-id-type="pmid">29926957</pub-id></mixed-citation>
              </ref>
              <ref id="cre2638-bib-0034">
                <mixed-citation publication-type="journal" id="cre2638-cit-0034"><string-name><surname>Schwarz</surname>, <given-names>S. R.</given-names></string-name>, <string-name><surname>Hirsch</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Hiergeist</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Kirschneck</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Muehler</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Hiller</surname>, <given-names>K. A.</given-names></string-name>, <string-name><surname>Maisch</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Al‐Ahmad</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Gessner</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Buchalla</surname>, <given-names>W.</given-names></string-name>, &amp; <string-name><surname>Cieplik</surname>, <given-names>F.</given-names></string-name> (<year>2021</year>). <article-title>Limited antimicrobial efficacy of oral care antiseptics in microcosm biofilms and phenotypic adaptation of bacteria upon repeated exposure</article-title>. <source>Clinical Oral Investigations</source>, <volume>25</volume>, <fpage>2939</fpage>–<lpage>2950</lpage>. <pub-id pub-id-type="doi">10.1007/s00784-020-03613-w</pub-id>
<pub-id pub-id-type="pmid">33033920</pub-id></mixed-citation>
              </ref>
              <ref id="cre2638-bib-0035">
                <mixed-citation publication-type="journal" id="cre2638-cit-0035"><string-name><surname>Sorsa</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Alassiri</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Grigoriadis</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Räisänen</surname>, <given-names>I. T.</given-names></string-name>, <string-name><surname>Pärnänen</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Nwhator</surname>, <given-names>S. O.</given-names></string-name>, <string-name><surname>Gieselmann</surname>, <given-names>D. R.</given-names></string-name>, &amp; <string-name><surname>Sakellari</surname>, <given-names>D.</given-names></string-name> (<year>2020</year>). <article-title>Active MMP‐8 (aMMP‐8) as a grading and staging biomarker in the periodontitis classification</article-title>. <source>Diagnostics (Basel, Switzerland)</source>, <volume>10</volume>(<issue>2</issue>), <elocation-id>61</elocation-id>. <pub-id pub-id-type="doi">10.3390/diagnostics10020061</pub-id>
<pub-id pub-id-type="pmid">31979091</pub-id></mixed-citation>
              </ref>
              <ref id="cre2638-bib-0036">
                <mixed-citation publication-type="journal" id="cre2638-cit-0036"><string-name><surname>Sorsa</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Bacigalupo</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Könönen</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Pärnänen</surname>, <given-names>P.</given-names></string-name>, &amp; <string-name><surname>Räisänen</surname>, <given-names>I. T.</given-names></string-name> (<year>2020</year>). <article-title>Host‐modulation therapy and chair‐side diagnostics in the treatment of peri‐implantitis</article-title>. <source>Biosensors</source>, <volume>10</volume>(<issue>5</issue>), <elocation-id>44</elocation-id>. <pub-id pub-id-type="doi">10.3390/bios10050044</pub-id>
<pub-id pub-id-type="pmid">32344881</pub-id></mixed-citation>
              </ref>
              <ref id="cre2638-bib-0037">
                <mixed-citation publication-type="journal" id="cre2638-cit-0037"><string-name><surname>Sorsa</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Gieselmann</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Arweiler</surname>, <given-names>N. B.</given-names></string-name>, &amp; <string-name><surname>Hernández</surname>, <given-names>M.</given-names></string-name> (<year>2017</year>). <article-title>A quantitative point‐of‐care test for periodontal and dental peri‐implant diseases</article-title>. <source>Nature Reviews Disease Primers</source>, <volume>3</volume>, <elocation-id>17069</elocation-id>. <pub-id pub-id-type="doi">10.1038/nrdp.2017.69</pub-id>
</mixed-citation>
              </ref>
              <ref id="cre2638-bib-0038">
                <mixed-citation publication-type="miscellaneous" id="cre2638-cit-0038"><string-name><surname>Sorsa</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Gieselmann</surname>, <given-names>D.‐R.</given-names></string-name>, <string-name><surname>Korvuo</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Maier</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Mäntylä</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Råman</surname>, <given-names>I.</given-names></string-name>, &amp; <string-name><surname>Tiisala</surname>, <given-names>S.</given-names></string-name> (<year>2019</year>). <italic toggle="yes">MMP‐8 activation product, its determination and use</italic> (U.S. Patent No. 10,488,415). U.S. Patent and Trademark Office.</mixed-citation>
              </ref>
              <ref id="cre2638-bib-0039">
                <mixed-citation publication-type="journal" id="cre2638-cit-0039"><string-name><surname>Sorsa</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Gursoy</surname>, <given-names>U. K.</given-names></string-name>, <string-name><surname>Nwhator</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Hernandez</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Tervahartiala</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Leppilahti</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Gursoy</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Könönen</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Emingil</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Pussinen</surname>, <given-names>P. J.</given-names></string-name>, &amp; <string-name><surname>Mäntylä</surname>, <given-names>P.</given-names></string-name> (<year>2016</year>). <article-title>Analysis of matrix metalloproteinases, especially MMP‐8, in gingival creviclular fluid, mouthrinse and saliva for monitoring periodontal diseases</article-title>. <source>Periodontology 2000</source>, <volume>70</volume>(<issue>1</issue>), <fpage>142</fpage>–<lpage>163</lpage>. <pub-id pub-id-type="doi">10.1111/prd.12101</pub-id>
<pub-id pub-id-type="pmid">26662488</pub-id></mixed-citation>
              </ref>
              <ref id="cre2638-bib-0040">
                <mixed-citation publication-type="journal" id="cre2638-cit-0040"><string-name><surname>Sorsa</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Sahni</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Buduneli</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Gupta</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Räisänen</surname>, <given-names>I. T.</given-names></string-name>, <string-name><surname>Golub</surname>, <given-names>L. M.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>H.‐S.</given-names></string-name>, <string-name><surname>Pätilä</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Bostanci</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Meurman</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Pärnänen</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Nwhator</surname>, <given-names>S. O.</given-names></string-name>, <string-name><surname>Singla</surname>, <given-names>M.</given-names></string-name>, &amp; <string-name><surname>Gauba</surname>, <given-names>K.</given-names></string-name> (<year>2021</year>). <article-title>Active matrix metalloproteinase‐8 (aMMP‐8) point‐of‐care test (POCT) in the COVID‐19 pandemic</article-title>. <source>Expert Review of Proteomics</source>, <volume>18</volume>, <fpage>707</fpage>–<lpage>717</lpage>. <pub-id pub-id-type="doi">10.1080/14789450.2021.1976151</pub-id>
<pub-id pub-id-type="pmid">34468272</pub-id></mixed-citation>
              </ref>
              <ref id="cre2638-bib-0041">
                <mixed-citation publication-type="journal" id="cre2638-cit-0041"><string-name><surname>Tian</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Puganen</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Alakomi</surname>, <given-names>H. L.</given-names></string-name>, <string-name><surname>Uusitupa</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Saarela</surname>, <given-names>M.</given-names></string-name>, &amp; <string-name><surname>Yang</surname>, <given-names>B.</given-names></string-name> (<year>2018</year>). <article-title>Antioxidative and antibacterial activities of aqueous ethanol extracts of berries, leaves, and branches of berry plants</article-title>. <source>Food Research International (Ottawa, Ont.)</source>, <volume>106</volume>, <fpage>291</fpage>–<lpage>303</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodres.2017.12.071</pub-id>
<pub-id pub-id-type="pmid">29579930</pub-id></mixed-citation>
              </ref>
              <ref id="cre2638-bib-0042">
                <mixed-citation publication-type="journal" id="cre2638-cit-0042"><string-name><surname>Yahfoufi</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Alsadi</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Jambi</surname>, <given-names>M.</given-names></string-name>, &amp; <string-name><surname>Matar</surname>, <given-names>C.</given-names></string-name> (<year>2018</year>). <article-title>The immunomodulatory and anti‐inflammatory role of polyphenols</article-title>. <source>Nutrients</source>, <volume>10</volume>(<issue>11</issue>), <elocation-id>1618</elocation-id>. <pub-id pub-id-type="doi">10.3390/nu10111618</pub-id>
<pub-id pub-id-type="pmid">30400131</pub-id></mixed-citation>
              </ref>
              <ref id="cre2638-bib-0043">
                <mixed-citation publication-type="journal" id="cre2638-cit-0043"><string-name><surname>Ziebolz</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Schmalz</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Gollasch</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Eickholz</surname>, <given-names>P.</given-names></string-name>, &amp; <string-name><surname>Rinke</surname>, <given-names>S.</given-names></string-name> (<year>2017</year>). <article-title>Microbiological and aMMP‐8 findings depending on peri‐implant disease in patients undergoing supportive implant therapy</article-title>. <source>Diagnostic Microbiology and Infectious Disease</source>, <volume>88</volume>(<issue>1</issue>), <fpage>47</fpage>–<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1016/j.diagmicrobio.2017.02.008</pub-id>
<pub-id pub-id-type="pmid">28274501</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
